Could it be?Bruce said in an interview the other day that they have not announced the identity of the research partner yet for the US shipment announced.
Beclley Canopy does work with Johns Hopkins University.
https://beckleyfoundation.org/science/collaborations/
Also, recently an article
https://hub.jhu.edu/2018/10/02/dea-schedules-cbd-drug-epidiolex/
Johns Hopkins Bloomberg School of Public Health researcher Caleb Alexander, who co-directs the Center for Drug Safety and Effectiveness, chaired the FDA advisory committee that recommended the agency's approval of the drug
Hmmmmmm.... maybe, possibly, thoughts?